相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glecaprevir/pibrentasvir plus sofosbuvir plus ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings
Michelle T. Martin et al.
JOURNAL OF HEPATOLOGY (2021)
Retreatment of patients with chronic hepatitis C, subtype 1b and cirrhosis, who failed previous direct-acting antiviral therapy including first- and second-generation NS5A inhibitors with ombitasvir/paritaprevir/ritonavir, dasabuvir plus sofosbuvir plus ribavirin
Sergii V. Fedorchenko et al.
JOURNAL OF VIRAL HEPATITIS (2020)
Quadruple Therapy Offers High SVR Rates in Patients with HCV Genotype 4 with Previous Treatment Failure
Yousry Esam-Eldin Abo-amer et al.
ADVANCES IN VIROLOGY (2020)
Sofosbuvir/velpatasvir ± ribavirin for retreatment of patients with chronic hepatitis C virus infection and advanced fibrosis failing to a previous DAA combination regimen
Giuseppina Brancaccio et al.
JOURNAL OF HEPATOLOGY (2019)
Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure
Tommaso Lorenzo Parigi et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA
J. Chhatwal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals
Namiki Izumi et al.
HEPATOLOGY INTERNATIONAL (2018)
Direct acting antivirals failure: cause and retreatment options
Lucia Parlati et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Sofosbuvir-Velpatasvir With Ribavirin for 24 Weeks in Hepatitis C Virus Patients Previously Treated With a Direct-Acting Antiviral Regimen
Edward J. Gane et al.
HEPATOLOGY (2017)
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
M. Bourliere et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hepatitis C genotype 4: The past, present, and future
Tawhida Y. Abdel-Ghaffar et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
分享论文
